DK1934207T3 - Substituerede 4-phenylpiperidiner til anvendelse som renininhibitorer - Google Patents

Substituerede 4-phenylpiperidiner til anvendelse som renininhibitorer

Info

Publication number
DK1934207T3
DK1934207T3 DK07820887T DK07820887T DK1934207T3 DK 1934207 T3 DK1934207 T3 DK 1934207T3 DK 07820887 T DK07820887 T DK 07820887T DK 07820887 T DK07820887 T DK 07820887T DK 1934207 T3 DK1934207 T3 DK 1934207T3
Authority
DK
Denmark
Prior art keywords
phenylpiperidines
substituted
renin inhibitors
renin
inhibitors
Prior art date
Application number
DK07820887T
Other languages
English (en)
Inventor
Peter Herold
Robert Mah
Stefan Stutz
Vincenzo Tschinke
Aleksandar Stojanovic
Dirk Behnke
Nathalie Jotterand
Stjepan Jelakovic
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Application granted granted Critical
Publication of DK1934207T3 publication Critical patent/DK1934207T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
DK07820887T 2006-10-04 2007-10-03 Substituerede 4-phenylpiperidiner til anvendelse som renininhibitorer DK1934207T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06121772A EP1911758A1 (en) 2006-10-04 2006-10-04 Phenyl piperidine derivatives for use as renin inhibitors
PCT/EP2007/060510 WO2008040764A1 (en) 2006-10-04 2007-10-03 Substituted 4-phenyl piperidines for use as renin inhibitors

Publications (1)

Publication Number Publication Date
DK1934207T3 true DK1934207T3 (da) 2009-06-02

Family

ID=37946086

Family Applications (1)

Application Number Title Priority Date Filing Date
DK07820887T DK1934207T3 (da) 2006-10-04 2007-10-03 Substituerede 4-phenylpiperidiner til anvendelse som renininhibitorer

Country Status (17)

Country Link
US (1) US7625893B2 (da)
EP (2) EP1911758A1 (da)
JP (1) JP2009532443A (da)
CN (1) CN101415703B (da)
AR (1) AR063124A1 (da)
AT (1) ATE425159T1 (da)
BR (1) BRPI0716114A2 (da)
CA (1) CA2642455A1 (da)
DE (1) DE602007000679D1 (da)
DK (1) DK1934207T3 (da)
ES (1) ES2322629T3 (da)
IL (1) IL193476A0 (da)
PL (1) PL1934207T3 (da)
PT (1) PT1934207E (da)
SI (1) SI1934207T1 (da)
TW (1) TW200831499A (da)
WO (1) WO2008040764A1 (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0609534A2 (pt) * 2005-03-31 2010-04-13 Speedel Experimenta Ag piperidinas 3,4,5-substituìdas
TW200932241A (en) * 2007-12-05 2009-08-01 Speedel Experimenta Ag Organic compounds
JP5484069B2 (ja) 2007-12-19 2014-05-07 大日本住友製薬株式会社 二環性へテロ環誘導体
BRPI0910991A2 (pt) * 2008-04-02 2016-01-19 Novartis Ag piperidinas substituídas como compostos terapêuticos
KR20120109292A (ko) 2009-06-24 2012-10-08 다이닛본 스미토모 세이야꾸 가부시끼가이샤 Ｎ-치환-시클릭 아미노 유도체

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5194605A (en) * 1989-12-08 1993-03-16 Merck & Co., Inc. Cyclic renin inhibitors containing 2-substituted (3S,4S)-4-amino-5-cyclohexyl-3-hydroxy pentanoic acid, 2-substituted (3S,4S)-5-cyclohexyl-3,4-di-hydroxy pentanoic acid or 2-substituted (4S,5S)-5-amino-6-cyclohexyl-4-hydroxyhexanoic acid or its analogs
CA2031745A1 (en) * 1989-12-08 1991-06-09 William J. Greenlee Cyclic renin inhibitors containing 2-substituted(3s, 4s)-4-amino-5-cyclohexyl-3-hydroxy pentanoic acid, 2-substituted (3s, 4s)-5-cyclohexyl-3,4-dihydroxy-pentanoic acid or 2 -substituted (4s, 5s)-5-amino-6- yclohexyl-4-hydroxyhexanoic acid or its analogs
US6376672B1 (en) * 1999-04-27 2002-04-23 Hoffmann-La Roche Inc. Naphthalenylmethoxypiperidines as renin inhibitors
US20040204455A1 (en) * 2003-04-10 2004-10-14 Cody Wayne Livingston Piperidine derivative rennin inhibitors
AR053406A1 (es) * 2004-07-09 2007-05-09 Speedel Experimenta Ag Derivados de piperidina como inhibidores de renina. composiciones farmaceuticas

Also Published As

Publication number Publication date
SI1934207T1 (sl) 2009-08-31
IL193476A0 (en) 2009-05-04
AR063124A1 (es) 2008-12-30
ATE425159T1 (de) 2009-03-15
HK1119678A1 (en) 2009-03-13
CN101415703B (zh) 2012-04-25
DE602007000679D1 (de) 2009-04-23
BRPI0716114A2 (pt) 2013-09-24
EP1934207A1 (en) 2008-06-25
EP1911758A1 (en) 2008-04-16
JP2009532443A (ja) 2009-09-10
TW200831499A (en) 2008-08-01
US7625893B2 (en) 2009-12-01
EP1934207B1 (en) 2009-03-11
CN101415703A (zh) 2009-04-22
ES2322629T3 (es) 2009-06-23
PT1934207E (pt) 2009-05-21
WO2008040764A1 (en) 2008-04-10
US20090088426A1 (en) 2009-04-02
PL1934207T3 (pl) 2009-10-30
CA2642455A1 (en) 2008-04-10

Similar Documents

Publication Publication Date Title
DK2086939T3 (da) Pyridiacarboxamid som II-beta-HSDI-inhibitorer
DK2074108T3 (da) Renin-inhibitorer
DK2125748T3 (da) Acylaminopyrazol som FGFR inhibitorer
CY2017016I2 (el) Αναστολεις πρωτεασωματος
DK2383271T3 (da) Aminoquinoloner som GSK-3-inhibitorer
DK2041138T3 (da) Pyrroltriazinkinase-inhibitorer
DK2470546T3 (da) HEXAHYDROOXAZINOPTERIDIN- forbindelser til anvendelse som mTOR INHIBITORER
DK2024375T3 (da) Cyclopropyl-kondenserede indolobenzazepin-HCV-NS5B-hæmmere
DK2139892T3 (da) Substituerede pyrimidodiazepiner nyttige som PLK1-inhibitorer
DK2021335T3 (da) Heterocykliske forbindelser som C-FMS-kinasehæmmere
CR10831A (es) INHIBIDORES ESPIRO CETONA DE ACETIL-CoA CARBOXILASA
DK2331547T3 (da) Pyrrolopyrimidinforbindelser som CDK-inhibitorer
DK2094263T3 (da) 2-adamantyl-butyramidderivater som selektive 11 beta-hsd1-inhibitorer
DK2310095T3 (da) Makrocykliske quinoxalinforbindelser som hcv-ns3-protease-inhibitorer
DK2220070T3 (da) 2-benzylpyridazinonderivater som Met-kinaseinhibitorer
DK1926722T3 (da) Substituerede benzimidazoler som kinaseinhibitorer
DK2389382T3 (da) Aminoheterocykliske forbindelser anvendt som pde9-inhibitorer
DK2078001T3 (da) Diazepan-acetamidderivater som selektive 11-HSD1-inhibitorer
BRPI0807547A2 (pt) Inibidores de aspartil protease hetercíclicos
DK2308841T3 (da) Phlorizinanaloge som SGLT2-inhibitorer
DK2125777T3 (da) Spiro-substituerede forbindelser som angiogeneseinhibitorer
DK1937671T3 (da) Benzimidazolthiophenforbindelser som PLK-inhibitorer
DK2010496T3 (da) 4-anilinoquinolin-3-carbonsyreamider som CSF-1R-kinaseinhibitorer
DK1994015T3 (da) Dibenzylaminderivater som CETP-hæmmere
DK2032535T3 (da) Spiro-cycliske nitriler som protease-inhibitorer